Cargando…

Urine cell‐free DNA as a promising biomarker for early detection of non‐small cell lung cancer

BACKGROUND: While blood‐derived cell‐free DNA has been shown to be a candidate biomarker able to provide diagnostic and prognostic insight in cancer patients, little is known regarding the potential application of urine cell‐free DNA (ucfDNA) in diagnosis of cancer. Thus, the aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Sai, Ren, Xiao-Dong, Guo, Li-Fang, Qu, Xue-Mei, Shang, Mei-Yun, Dai, Xiao-Tian, Huang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439414/ https://www.ncbi.nlm.nih.gov/pubmed/32281142 http://dx.doi.org/10.1002/jcla.23321

Ejemplares similares

Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
por: Qi, Ting, et al.
Publicado: (2023)

Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer
por: Ren, Sai, et al.
Publicado: (2023)

Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer
por: Xia, Yun, et al.
Publicado: (2016)

5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer
por: Zhang, Ji, et al.
Publicado: (2018)

Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients
por: Bach, Sander, et al.
Publicado: (2021)

Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
por: Huang, Ao, et al.
Publicado: (2016)

Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer
por: Dai, Bai, et al.
Publicado: (2019)

Urine cell-free microRNA as biomarkers for transitional cell carcinoma
por: Geva, Gil A., et al.
Publicado: (2017)

Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
por: Gianni, Caterina, et al.
Publicado: (2022)

Sensitive detection of low-abundance in-frame deletions in EGFR exon 19 using novel wild-type blockers in real-time PCR
por: Ren, Xiao-Dong, et al.
Publicado: (2019)

Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma
por: You, Yongke, et al.
Publicado: (2021)

Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Cong, et al.
Publicado: (2022)

Corrigendum: Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis
por: Huang, Yun-Ju, et al.
Publicado: (2022)

The art of obtaining a high yield of cell-free DNA from urine
por: Augustus, Elien, et al.
Publicado: (2020)

Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine
por: Murugesan, Kanagavel, et al.
Publicado: (2019)

Label Free Detection of Sensitive Mid-Infrared Biomarkers of Glomerulonephritis in Urine Using Fourier Transform Infrared Spectroscopy
por: Yu, Mei-Ching, et al.
Publicado: (2017)

Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19
por: Jin, Xin, et al.
Publicado: (2023)

Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome
por: Sun, Yi, et al.
Publicado: (2022)

Urine cell-free DNA is a biomarker for nephroblastomatosis or Wilms Tumor in PIK3CA-related overgrowth spectrum (PROS)
por: Waberski, Marta Biderman, et al.
Publicado: (2018)

Cell-free mitochondrial DNA in human follicular fluid: a promising bio-marker of blastocyst developmental potential in women undergoing assisted reproductive technology
por: Liu, Yu, et al.
Publicado: (2019)

Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis
por: Xue, Wei-Xiao, et al.
Publicado: (2020)

Albumin‐to‐fibrinogen ratio as a promising biomarker to predict clinical outcome of non‐small cell lung cancer individuals
por: Li, Shu‐Qi, et al.
Publicado: (2018)

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
por: Yuan, Zuyang, et al.
Publicado: (2020)

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
por: Ai, Bo, et al.
Publicado: (2016)

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022)

Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non–small-cell lung carcinoma
por: Luo, Ruihan, et al.
Publicado: (2020)

Cell-free DNA in the management of prostate cancer: Current status and future prospective
por: He, Wei, et al.
Publicado: (2023)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients
por: Salvi, Samanta, et al.
Publicado: (2015)

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
por: Smith, Christopher G., et al.
Publicado: (2020)

Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients
por: Mouliere, Florent, et al.
Publicado: (2021)

Diagnosing Pulmonary Tuberculosis by Using Sequence-Specific Purification of Urine Cell-Free DNA
por: Oreskovic, Amy, et al.
Publicado: (2021)

Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of Cancer
por: Dermody, Sarah M., et al.
Publicado: (2022)

Cell‐free DNA as a biomarker of aging
por: Teo, Yee Voan, et al.
Publicado: (2018)

Collagen Peptides in Urine: A New Promising Biomarker for the Detection of Colorectal Liver Metastases
por: Bröker, Mirelle E. E., et al.
Publicado: (2013)

Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC
por: Wu, Zhen, et al.
Publicado: (2019)

Cell-free DNA as a promising marker for risk stratification of pulmonary embolism
por: Neto-Neves, Evandro M
Publicado: (2013)

Potential urine biomarkers for gestational hypertension and preeclampsia
por: Guo, Hong-Xia, et al.
Publicado: (2019)

Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
por: Kim, Kyongchol, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ttrrm9dg4bg5tbvn4n6s2quoc0